The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review
Open Access
- 29 January 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in Insights into Imaging
- Vol. 4 (2), 163-175
- https://doi.org/10.1007/s13244-013-0219-y
Abstract
This systematic review aimed to assess the role of magnetic resonance imaging (MRI) in evaluating residual disease extent and the ability to detect pathologic complete response (pCR) after neoadjuvant chemotherapy for invasive breast cancer.Keywords
This publication has 55 references indexed in Scilit:
- Locally Advanced Breast Cancer: MR Imaging for Prediction of Response to Neoadjuvant Chemotherapy—Results from ACRIN 6657/I-SPY TRIALRadiology, 2012
- Diagnostic Performance of Magnetic Resonance Imaging for Assessing Tumor Response in Patients With HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy is Associated With Molecular Biomarker ProfileClinical Breast Cancer, 2012
- Breast Cancer: Evaluation of Response to Neoadjuvant Chemotherapy with 3.0-T MR ImagingRadiology, 2011
- Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapyThe British Journal of Radiology, 2011
- Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer SubtypeJournal of Clinical Oncology, 2011
- Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imagingEuropean Radiology, 2010
- Diffusion-weighted MR Imaging: Pretreatment Prediction of Response to Neoadjuvant Chemotherapy in Patients with Breast CancerRadiology, 2010
- MRI-Model to Guide the Surgical Treatment in Breast Cancer Patients After Neoadjuvant ChemotherapyAnnals of Surgery, 2010
- Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancerBritish Journal of Cancer, 2008
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986